Close

Business & Industry

ACHEMA 2027 Strengthens India Process Industry Collaboration

DECHEMA, EEPC INDIA and Messe Frankfurt India brought together more than 200 industry leaders, business stakeholders and professionals from India’s process, chemical, pharmaceutical and engineering sectors at a Networking Evening in New Delhi on 8 September 2026. Held at...

Neuland Expands Peptide Manufacturing Capacity in India

Neuland Laboratories is accelerating its peptide manufacturing expansion, with the first of four planned modules now operational at its commercial peptide manufacturing site in Hyderabad. The company said the newly commissioned module is designed to meet growing customer demand...

Strengthening Supply Chain Visibility for Safe Medicines

A comprehensive survey of 5,000 patients across the United States, the United Kingdom, France, and Germany indicates that pharmaceutical manufacturers have a timely opportunity to build consumer trust through enhanced traceability. With six in 10 respondents voicing concern that...

Novo Nordisk and Orbis Medicines Partner on Oral Therapies for Cardiometabolic Diseases

Danish pharmaceutical company Novo Nordisk and biotechnology developer Orbis Medicines have entered into a drug discovery and licensing agreement valued at up to $1.4 billion to develop oral therapies for cardiometabolic diseases. The program aims to advance oral alternatives...

Choosing the Right Supply Chain Strategy for Pharma Growth – Live Webinar

Pharmaceutical and life sciences businesses face stringent requirements around batch control, traceability and compliance, which cannot be an afterthought when scaling warehouse operations and supporting pharma growth. Ryan Gibbs and Grant Smith will examine these supply chain considerations in an...

FDA Opens Door to Innovative Approaches for Psychedelic Drug Development Amid Mental Health Crisis

Senior officials at the US Food and Drug Administration have signaled that the agency is open to novel and innovative approaches in the clinical development of psychedelic drugs, citing the worsening mental health crisis across the United States. The...

ABEC Opens New Biopharmaceutical Manufacturing Facility in Wilson, North Carolina

ABEC is set to open a new manufacturing facility in Wilson, North Carolina, further strengthening its network of biopharmaceutical process equipment and consumables production. A ribbon-cutting ceremony to mark the occasion is scheduled for 24 September, with company leadership,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »